The global Pelvic Floor Electric Stimulator Market reached a size of USD 289.9 Million in 2024 and is projected to grow to USD 672.6 Million by 2033. The market is expected to grow at a CAGR of 9.8% during the forecast period from 2025 to 2033. This growth is driven by the increasing prevalence of pelvic floor disorders, rising awareness and acceptance of electrical stimulation therapy, and ongoing technological advancements.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Pelvic Floor Electric Stimulator Market Key Takeaways
- The global market size was valued at USD 289.9 Million in 2024 and is forecasted to reach USD 672.6 Million by 2033, growing at a CAGR of 9.8% during the forecast period (2025-2033).
- The rising prevalence of pelvic floor disorders globally due to lifestyle changes and obesity is a significant driving force.
- Increasing awareness and acceptance among healthcare providers and patients for non-invasive pelvic floor electric stimulation is stimulating market growth.
- Technological advancements such as programmability, adjustable intensity, biofeedback integration, and wireless connectivity enhance treatment efficacy and user convenience.
- The availability of various product types—mobile, fixed, and wearable—caters to different patient needs and preferences.
- North America dominates the market, driven by an aging population and advanced healthcare infrastructure.
Sample Request Link: https://www.imarcgroup.com/pelvic-floor-electric-stimulator-market/requestsample
Market Growth Factors
There is an increasing prevalence of pelvic floor disorders worldwide owing to changing lifestyles and rising obesity rates. The report highlights that childbirth-related injuries and conditions like urinary incontinence are major contributors to this trend. This has led to a growing patient base seeking effective treatments, thereby fueling the demand for pelvic floor electric stimulators, which offer a non-invasive and drug-free therapy option.
Awareness among healthcare professionals regarding the effectiveness of pelvic floor electric stimulators is expanding, leading to more frequent recommendations. Patients prefer these devices due to their safety, convenience, and ability to avoid surgical procedures, infection risks, and downtime. The growing acceptance of this therapy as a reliable treatment for pelvic floor dysfunction positively influences market growth.
Manufacturers are continuously introducing advanced features such as programmability, adjustable intensity levels, customizable treatment programs, compact designs, wireless connectivity, and integration of biofeedback and real-time monitoring. These innovations improve treatment experiences, patient compliance, and outcomes, strengthening the market. Healthcare providers favor devices with advanced technology to deliver enhanced patient care.
Market Segmentation
Breakup by Product Type:
- Mobile: Mobile pelvic floor electric stimulators are portable, compact, and often battery-operated, suitable for on-the-go use. They represented the largest market segment due to their convenience and mobility.
- Fixed: Fixed stimulators are designed for use in clinics or healthcare facilities. They offer enhanced functionality, higher intensity levels, and additional therapy options compared to mobile devices.
- Wearable: Wearable stimulators are designed to be worn on or inside the body, offering discreet, comfortable, and targeted stimulation throughout daily activities.
Breakup by Application:
- Urinary Incontinence: This segment holds the largest market share. Devices assist in strengthening pelvic floor muscles and reducing symptoms by improving muscle strength, coordination, and endurance.
- Neurodegenerative Diseases: Pelvic floor electric stimulators aid in managing pelvic floor dysfunction symptoms in conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries by reducing muscle spasms and restoring function.
- Sexual Dysfunction: Used in treating conditions like erectile dysfunction and female sexual arousal disorder, these devices enhance blood circulation, muscle tone, relaxation, and overall sexual well-being.
Regional Insights
North America dominates the pelvic floor electric stimulator market, holding the largest share. This dominance is attributed to the rising geriatric population, increasing prevalence of pelvic floor disorders such as urinary incontinence and pelvic organ prolapse, advancements in healthcare infrastructure and technologies, and growing awareness about treatment options.
Key Players
- ActivLife Technologies
- Athena Feminine Technologies Inc.
- Atlantic Therapeutics Ltd.
- Everyway Medical Instruments Co. Ltd.
- InControl Medical LLC
- TensCare Ltd.
- Utah Medical Products Inc.
- Zynex Inc.
Ask for Report Customization:
https://www.imarcgroup.com/request?type=report&id=8574&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
Comments (0)